• Founded in 2014, ONE-CHIP BIOTECHNOLOGY CO.，LTD is mainly engaged in the research, development and industrialization work of semiconductor integrated circuit biosensor chips and its related intelligent devices. The company’s products are applied to emerging fields such as gene testing, inspection of water quality and environmental protection, measurement of Internet of things. Headquartered in Suzhou,the company focuses on the development of sensor chips and water quality products, relying on the most concentrated semiconductor industry layout in Suzhou and the Yangtze River Delta region. The company was awarded as the Top 100 of Future Medical Devices, 2020-2021 -- Top 100 Innovative medical devices in China; The TOP100 Enterprises in Suzhou city, 2018; The first batch of “unicorn breeding enterprises” in Suzhou city, 2018; The most potential overseas students entrepreneurship enterprises of China, 2018; The top entrepreneurial team developed in Chengdu, 2019; The Most Valuable Investment Award" owned by China International Software Cooperation Fair, 2019, etc.
• The semiconductor biosensor technology, nano biochemical detection and gene sequencing independently developed by the company have been upgraded to the latest version, effectively solving the problems of large volume, high cost and low speed in the biochemical detection industry. Currently, the detection sensitivity and accuracy have been qualitatively improved. The core team has more than 10 years of experience and accumulation in cross-field technology research, reaching the international leading level. The company has a total of 110 intellectual property applications, covering patents, trademarks, integrated circuit layout and other property rights.
• The company focuses on disruptive technological innovation with unbreakable competitive advantages of differentiation, enabling the middle and lower reaches of multiple industries and driving explosive growth. The market capacity of genetic testing and biochemical testing of the Internet of things both reach 100 billion yuan, and have a long-termed and rapid growth trend, providing broad space for the development of the company. At present, there are nearly 70 prospective customers for water quality inspection and nearly 20 for gene test, including well-known domestic suppliers of diagnostic reagents and well-known third-party testing institutions. The company's core technology has been recognized by the capital market, and it has completed 3 rounds of equity financing of nearly 150 million yuan. The long-term goal is to become the“unicorn(bellwether)”in the field of semiconductor biochemical detection.